UMG, MedRhythms Partner on ‘Prescription Music’ for Stroke Patients

Universal Music Group will open its catalog of recordings to MedRhythms for treating patients who lose function to neurologic disease or injury, said the digital therapeutics company Wednesday. The neuroscience behind the MedRhythms “prescription music” platform, approved by the Food and Drug Administration, demonstrates how recorded songs “can profoundly impact the human brain” by targeting “specific neural circuitry to enhance clinical outcomes and boost neuroplasticity,” it said. Providing patients with music they enjoy “is a critical component” of the care they receive, it said. Research that shows that “auditory rhythm” can be used to directly target the “human motor system” to treat walking “deficits” caused by stroke, multiple sclerosis, Parkinson’s disease, Alzheimer’s and “cognitive impairment,” it said.